The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
The BIOMED-2 group developed and approved a set of multiplex Ig and T cell receptor PCR primers and successfully applied these to different well-defined WHO lymphoma entities with unprecedented high frequencies of malignant cases showing clonality. This approach has now become a worldwide standard of clonality testing in lymphoproliferations. While the clonality testing and assessment by GeneScan...